The S&P 500 posted a nominal gain on Friday as further clarity regarding the timeline for the development of a COVID-19 vaccine and much better-than-expected retail sales data and brought buyers back to the market.
The Dow Jones Industrial Average also joined the S&P in positive territory, both indices snapping a three-day losing streak driven by halted vaccine trials and continued wrangling in Washington over a new pandemic relief package.
However, the NASDAQ Composite ended the session lower.
Graphic: AP
Even so, they all posted gains on the week.
Pfizer Inc announced it could apply for US authorization for the COVID-19 vaccine it is developing with German partner BioNTech AG next month. Pfizer’s stock gained 3.8 percent.
“The two highest-level market movers are the vaccine timeline and stimulus optimism,” said Ross Mayfield, investment strategist at Robert W Baird & Co in Louisville, Kentucky. “Sometimes the market gets a reality check that even if we get a vaccine early next year that’s an incredibly aggressive and optimistic timeline.”
Retail sales last month blew past analyst expectations and consumer sentiment for this month surprised to the upside, according to two separate economic reports.
However, with previous stimulus having run its course, the outlook is uncertain unless Washington can reach an agreement on a fresh round of fiscal aid.
“It’s important from the retail sales data to see that the consumer is not just limping along, but exceeding expectations,” Mayfield added. “I don’t know how long this can continue without stimulus, but it’s heartening to see the consumer has held up pretty well, despite some dire expectations.”
On the stimulus front, US Secretary of the Treasury Steven Mnuchin told US House of Representatives Speaker Nancy Pelosi that US President Donald Trump would “weigh in” with US Senate Majority Leader Mitch McConnell if an agreement is reached on a new pandemic relief package.
However, House Republican leader Kevin McCarthy said he does not expect an agreement to be reached ahead of the Nov. 3 US presidential election as long as Pelosi is involved.
The Dow Jones Industrial Average on Friday rose 112.11 points, or 0.39 percent, to 28,606.31, the S&P 500 gained 0.47 points, or 0.01 percent, to 3,483.81 and the NASDAQ Composite dropped 42.32 points, or 0.36 percent, to 11,671.56.
For the week, the Dow eked out a 0.07 percent gain, the S&P 500 added 0.2 percent and the NASDAQ Composite rose 0.8 percent.
Of the 11 major sectors in the S&P 500, seven ended the session in the black. While utilities had the largest percentage gain, energy suffered the biggest loss.
Third-quarter reporting season started this week, with 49 of the companies in the S&P 500 having reported.
Of those, 86 percent have cleared the low bar set by expectations, Refinitiv data showed.
Oil services company Schlumberger NV posted its third straight quarterly loss due to falling crude prices and plunging demand. Its shares dropped 8.8 percent.
Railroad operator Kansas City Southern shed 2.7 percent and transportation and logistics company J.B. Hunt Transport Services Inc tumbled 9.7 percent after the companies’ quarterly results were hit dropping shipping demand.
Shares of fitness company Peloton Interactive Inc lost 3.7 percent after announcing a recall of faulty pedals on its popular exercise bikes.
Declining issues outnumbered advancing ones on the New York Stock Exchange by a 1.30-to-1 ratio; on NASDAQ, a 1.07-to-1 ratio favored decliners.
The S&P 500 posted 50 new 52-week highs and no new lows; the NASDAQ Composite recorded 98 new highs and 20 new lows.
Volume on US exchanges was 8.82 billion shares, compared with the 9.31 billion average over the past 20 trading days.
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”
Sales in the retail, and food and beverage sectors last month continued to rise, increasing 0.7 percent and 13.6 percent respectively from a year earlier, setting record highs for the month of March, the Ministry of Economic Affairs said yesterday. Sales in the wholesale sector also grew last month by 4.6 annually, mainly due to the business opportunities for emerging applications related to artificial intelligence (AI) and high-performance computing technologies, the ministry said in a report. The ministry forecast that retail, and food and beverage sales this month would retain their growth momentum as the former would benefit from Tomb Sweeping Day
Thousands of parents in Singapore are furious after a Cordlife Group Ltd (康盛人生集團), a major operator of cord blood banks in Asia, irreparably damaged their children’s samples through improper handling, with some now pursuing legal action. The ongoing case, one of the worst to hit the largely untested industry, has renewed concerns over companies marketing themselves to anxious parents with mostly unproven assurances. This has implications across the region, given Cordlife’s operations in Hong Kong, Macau, Indonesia, the Philippines and India. The parents paid for years to have their infants’ cord blood stored, with the understanding that the stem cells they contained